Sotera Health Company (SHC)

Sotera Health Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,125	1,100	1,049	1,004	931.48	818.16
Revenue Growth (YoY)	2.40%	4.88%	4.54%	7.75%	13.85%	5.12%
Cost of Revenue	500.09	498.15	472.13	446.68	412.81	374.59
Gross Profit	624.44	602.3	577.16	557	518.67	443.57
Selling, General & Admin	217.92	204.75	186.37	166.18	149.36	136.6
Operating Expenses	273.43	266.79	250.16	229.12	213.14	195.63
Operating Income	351.01	335.51	326.99	327.89	305.53	247.94
Interest Expense	-164.06	-164.69	-142.88	-80.14	-74.19	-215.26
Currency Exchange Gain (Loss)	-2.3	-0.2	-0.16	-0.15	-1.35	5.23
Other Non Operating Income (Expenses)	4.94	0.12	2.38	-0.46	3.56	4.16
EBT Excluding Unusual Items	189.59	170.74	186.34	247.14	233.55	42.07
Gain (Loss) on Sale of Investments	-	-	-	-9.61	-	-
Legal Settlements	-97.64	-32.69	-80.31	-480.64	-45.66	-36.67
Other Unusual Items	-0.16	-24.17	-	-	-15.58	-44.26
Pretax Income	91.79	113.87	106.03	-243.11	175.72	-38.86
Income Tax Expense	67.77	69.48	54.65	-9.54	58.6	-1.37
Earnings From Continuing Operations	24.02	44.4	51.38	-233.57	117.12	-37.49
Minority Interest in Earnings	-	-	-	-	-0.24	-1.13
Net Income	24.02	44.4	51.38	-233.57	116.88	-38.62
Preferred Dividends & Other Adjustments	0.06	0.06	0.29	-	1.52	-
Net Income to Common	23.96	44.34	51.09	-233.57	115.36	-38.62
Net Income Growth	-40.09%	-13.58%	-	-	-	-
Shares Outstanding (Basic)	283	283	281	280	279	238
Shares Outstanding (Diluted)	285	285	283	280	279	238
Shares Change (YoY)	0.28%	0.60%	1.12%	0.26%	17.54%	2.28%
EPS (Basic)	0.08	0.16	0.18	-0.83	0.41	-0.16
EPS (Diluted)	0.08	0.16	0.18	-0.83	0.41	-0.16
EPS Growth	-39.59%	-12.89%	-	-	-	-
Free Cash Flow	112.7	45.09	-362.71	95.58	179.38	67.08
Free Cash Flow Per Share	0.40	0.16	-1.28	0.34	0.64	0.28
Gross Margin	55.53%	54.73%	55.01%	55.50%	55.68%	54.22%
Operating Margin	31.21%	30.49%	31.16%	32.67%	32.80%	30.30%
Profit Margin	2.13%	4.03%	4.87%	-23.27%	12.38%	-4.72%
Free Cash Flow Margin	10.02%	4.10%	-34.57%	9.52%	19.26%	8.20%
EBITDA	518.5	501.78	487.33	475.63	458.68	393.5
EBITDA Margin	46.11%	45.60%	46.44%	47.39%	49.24%	48.10%
D&A For EBITDA	167.49	166.28	160.34	147.75	153.15	145.56
EBIT	351.01	335.51	326.99	327.89	305.53	247.94
EBIT Margin	31.21%	30.49%	31.16%	32.67%	32.80%	30.30%
Effective Tax Rate	73.83%	61.01%	51.54%	-	33.35%	-
Revenue as Reported	1,125	1,100	1,049	1,004	931.48	818.16

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q